Recent advancements in CRISPR-Cas9 gene editing are being applied to create invisible cells that the human immune system will not target after transplantation. This critical innovation addresses one of the most persistent bottlenecks in regenerative medicine: the immune response that leads to the
By excluding cardboard outer boxes and paper leaflets, the new satchel focuses specifically on the difficult-to-recycle multi-material blisters that plague traditional waste management. This collaborative initiative, led by Consumer Healthcare Products (CHP) Australia in partnership with
Submerged cultivation of Fomitopsis pinicola mycelium offers a controlled alternative to wild harvesting, allowing researchers to precisely manipulate chemical outputs in liquid tanks. This wood-decaying fungus, colloquially known as the Red-Belted Conk, has occupied a prominent place in
ALLO-329 Shows Rapid Benefits for Systemic Sclerosis, an experimental therapy that utilizes healthy donor cells to create an available, pre-manufactured product designed to address the high cost and logistical hurdles of cell therapy. Systemic sclerosis, a devastating autoimmune condition often
Biological hydrogen generation is often considered economically unfeasible because of the high costs associated with synthetic growth media and feedstocks. Despite this, the global push for a decarbonized energy grid has turned hydrogen into a critical focal point, primarily because its energy
Establishing mathematical models for population growth highlights how plant-based supplements can match the theoretical carrying capacity of full-serum media. As we navigate the bioprocessing landscape of 2026, the reliance on animal-derived components like fetal bovine serum and newborn calf serum
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48